Literature DB >> 20060762

Effects of soy diet on inflammation-induced primary and secondary hyperalgesia in rat.

Jasenka Borzan1, Jill M Tall, Chengshui Zhao, Richard A Meyer, Srinivasa N Raja.   

Abstract

Soy consumption is said to prevent or treat atherosclerosis, cancer, pain, and memory deficits, but experimental and clinical evidence to support these claims are lacking. We used in vivo models of inflammation to determine whether a soy diet reduces primary or secondary hyperalgesia. In all three experiments, rats were fed either a soy- or casein-based diet for at least 2 weeks before induction of inflammation and for the duration of experiments. Mechanical and heat paw withdrawal thresholds and edema were measured before and several times after induction of inflammation. Primary hyperalgesia was assessed in two models: unilateral intraplantar injection with 0.1 ml of 25% complete Freund's adjuvant (CFA) or 0.1 ml of 1% carrageenan. Unilateral injection of the intra-articular knee space with 25% CFA (0.1 ml) was used to determine the effects of soy in a model of secondary hyperalgesia. Following intraplantar injection of CFA, soy-fed animals exhibited significantly less paw edema, mechanical allodynia, and heat hyperalgesia compared to casein-fed animals. In the carrageenan model of paw inflammation, soy-fed animals were also less allodynic to mechanical stimuli, than were casein-fed animals, but showed no diet based differences in paw edema or heat hyperalgesia. Soy diet did not affect any of the outcome measures after the intra-articular injection of CFA. Our results suggest that a soy diet significantly decreases aspects of inflammation-induced primary, but not secondary, hyperalgesia in rats. Copyright 2009 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060762      PMCID: PMC2891824          DOI: 10.1016/j.ejpain.2009.12.002

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  48 in total

1.  Soy-containing diet suppresses chronic neuropathic sensory disorders in rats.

Authors:  Y Shir; R Sheth; J N Campbell; S N Raja; Z Seltzer
Journal:  Anesth Analg       Date:  2001-04       Impact factor: 5.108

2.  Role of gonadal hormones in formalin-induced pain responses of male rats: modulation by estradiol and naloxone administration.

Authors:  A M Aloisi; I Ceccarelli
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Authors:  P W Wacnik; L J Eikmeier; T R Ruggles; M L Ramnaraine; B K Walcheck; A J Beitz; G L Wilcox
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

4.  Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.

Authors:  P Honore; N M Luger; M A Sabino; M J Schwei; S D Rogers; D B Mach; P F O'keefe; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  Consumption of soy diet before nerve injury preempts the development of neuropathic pain in rats.

Authors:  Y Shir; S N Raja; C S Weissman; J N Campbell; Z Seltzer
Journal:  Anesthesiology       Date:  2001-11       Impact factor: 7.892

6.  Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats.

Authors:  F Wei; S Zou; A Young; R Dubner; K Ren
Journal:  J Altern Complement Med       Date:  1999-10       Impact factor: 2.579

7.  Use of complementary therapies for arthritis among patients of rheumatologists.

Authors:  J K Rao; K Mihaliak; K Kroenke; J Bradley; W M Tierney; M Weinberger
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

8.  Long-term trends in the use of complementary and alternative medical therapies in the United States.

Authors:  R C Kessler; R B Davis; D F Foster; M I Van Rompay; E E Walters; S A Wilkey; T J Kaptchuk; D M Eisenberg
Journal:  Ann Intern Med       Date:  2001-08-21       Impact factor: 25.391

9.  Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

Authors:  C C Chan; S Boyce; C Brideau; S Charleson; W Cromlish; D Ethier; J Evans; A W Ford-Hutchinson; M J Forrest; J Y Gauthier; R Gordon; M Gresser; J Guay; S Kargman; B Kennedy; Y Leblanc; S Leger; J Mancini; G P O'Neill; M Ouellet; D Patrick; M D Percival; H Perrier; P Prasit; I Rodger
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

10.  Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

Authors:  P Honore; S D Rogers; M J Schwei; J L Salak-Johnson; N M Luger; M C Sabino; D R Clohisy; P W Mantyh
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

View more
  4 in total

1.  Reduction of inflammation in chronic pancreatitis using a soy bread intervention: A feasibility study.

Authors:  Jennifer Ahn-Jarvis; Erin Lombardo; Zobeida Cruz-Monserrate; Niharika Badi; Olivia Crowe; Sabrina Kaul; Hannah Komar; Somashekar G Krishna; Gregory B Lesinski; Thomas A Mace; Mitchell L Ramsey; Kristen Roberts; Kyle Stinehart; Madelyn Traczek; Darwin L Conwell; Yael Vodovotz; Phil A Hart
Journal:  Pancreatology       Date:  2020-06-06       Impact factor: 3.996

2.  Laboratory environmental factors and pain behavior: the relevance of unknown unknowns to reproducibility and translation.

Authors:  Jeffrey S Mogil
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

3.  Evaluation of the antirheumatic effects of isoflavone-free soy protein isolate and etanercept in rats with adjuvant-induced arthritis.

Authors:  Nahla E El-Ashmawy; Eman G Khedr; Maha M Shamloula; Maha M Kamel
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-21

Review 4.  Breast cancer pain management - a review of current & novel therapies.

Authors:  Aanchal Satija; Syed Mehmood Ahmed; Rahul Gupta; Arif Ahmed; Shiv Pratap Singh Rana; Suraj Pal Singh; Seema Mishra; Sushma Bhatnagar
Journal:  Indian J Med Res       Date:  2014-02       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.